Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer TrendingStockAlerts · Feb 27, 2025
Julius Clinical Strengthens its European Capabilities by Expanding Operations in Poland TrendingStockAlerts · Feb 26, 2025
Esphera SynBio's Exosome Tech Featured on Advancements with Ted Danson on the Bloomberg cable and satellite network TrendingStockAlerts · Feb 24, 2025
FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease TrendingStockAlerts · Feb 23, 2025
Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight TrendingStockAlerts · Feb 22, 2025
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development TrendingStockAlerts · Feb 21, 2025
BioArctic's global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing TrendingStockAlerts · Feb 20, 2025
Enzymatica AB Year-end report 2024: Strong performance in core markets - preparing for international growth TrendingStockAlerts · Feb 19, 2025
The Galien Foundation Announces New Prix Galien UK Award Category for "Best Health Equity Innovation" TrendingStockAlerts · Feb 18, 2025
Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer TrendingStockAlerts · Feb 17, 2025
Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference TrendingStockAlerts · Feb 16, 2025
